EMEA-001809-PIP01-15-M02 - paediatric investigation plan
relebactam (MK-7655A)
cilastatin sodium
imipenem monohydrate
PIPHuman
Merck Sharp & Dohme (Europe), Inc.
Tel. +33 180464738
Email: pip.information@merck.com
P/0279/2020: EMA decision of 24 July 2020 on the acceptance of a modification of an agreed paediatric investigation plan for imipenem (monohydrate) / cilastatin (sodium) / relebactam (MK-7655A) (Recarbrio), (EMEA-001809-PIP01-15-M02)